|
Sign In to gain access to subscriptions and/or personal tools.
|
Glycaemic memory
Clifford J Bailey
School of Life and Health Sciences, Aston University, Birmingham, UK, c.j.bailey{at}aston.ac.uk
Caroline Day
School of Life and Health Sciences, Aston University, Birmingham, UK
Glycaemic memory describes the deferred effects of prior glycaemic status on diabetic complications later in life, independent of more recent glycaemic control. Prospective evidence for glycaemic memory derives from extended studies after trials that compared intensive versus standard glycaemic control. These studies in type 1 diabetes (e.g. DCCT) and type 2 diabetes (e.g. UKPDS) have shown that a period of poor glycaemic control earlier in the course of the disease is associated with an increased burden of complications much later in the course of the disease, even when glycaemic control is latterly improved. The Veterans Affairs Diabetes Trial suggested that more than 12—15 years of poor control in older type 2 patients minimised the benefits of subsequently improved glycaemic control. The delayed adverse effects of hyperglycaemia emphasise the importance of effective early glycaemic control.
Key Words: glycaemic memory • hyperglycaemic memory • intensive • glycaemic control
References
- The Diabetes Control and Complications Trial research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.[Abstract/Free Full Text]
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study research group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-53.[Abstract/Free Full Text]
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Holman RR, Paul SK, Bethel MA et al. 10-Year follow-up of intensive glucose control in type 2 Diabetes. UKPDS 80. N Engl J Med 2008; 10 Sep [Epub ahead of print].
- Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006; 49:1711-21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Duckworth W. Veterans Affairs Diabetes Trial. 68th American Diabetes Association, Annual Conference, 6-10 June 2008, San Francisco, USA.{1}
- Gaede P., Vedel P., Larsen N. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.[Abstract/Free Full Text]
- Gaede P., Lund-Andersen H., Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358:580-91.[Abstract/Free Full Text]
- Ukpds Group. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13:1-11.[Medline]
[Order article via Infotrieve]
- Diabetes UK Audit Project. Audit shows 10-year delay in diagnosing type 2 diabetes. Diabetes Update 2000; Winter:1.
- Haffner SJ, Cassells H. Hyperglcemia as a cardiovascular risk factor. Am J Med 2003; 115(8A):6S-11S.[Medline]
[Order article via Infotrieve]
- The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26:688-96.[Abstract/Free Full Text]
- Khaw KT, Wareham N., Bingham S. et al. Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation Into Cancer in Norfolk. Ann Intern Med 2004; 141:413-20.[Abstract/Free Full Text]
- Ceriello A., Esposito K., Piconi L. et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-54.[Abstract/Free Full Text]
- The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-59.[Abstract/Free Full Text]
- Kosiborod M., Inzucchi S., Krumholz HM et al. Glucometrics in patients hospitalized with acute myocardial infarction. Circulation 2008; 117:1018-27.[Abstract/Free Full Text]
- The Advance collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-72.[Abstract/Free Full Text]
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-20.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA 2002; 287:2570-81.[Abstract/Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 5,
242-247 (2008)
DOI: 10.1177/1474651408098784
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S. H Song and T. A Gray
Management of type 2 diabetes and lipids: a critique of the NICE guidelines 2008
The British Journal of Diabetes & Vascular Disease,
March 1, 2009;
9(2):
69 - 74.
[Abstract]
[PDF]
|
|
|
|
|
